Is Your Period Telling You Something? Early Signs Most Women Miss
Last Updated:
According to Apollo Health of the Nation data, the incidence of type 2 diabetes among postmenopausal women has soared from 14% to 40%, while obesity affects up to 86% of women
For decades, menstruation has been viewed as a monthly inconvenience or a reproductive checkpoint. Rarely, however, is it recognised for what it truly is: a vital sign. Just like blood pressure or heart rate, the menstrual cycle offers critical insight into a woman's overall health—insights that are too often overlooked or misunderstood.
In India, conversations around women's health still pivot primarily around fertility and childbirth. But what about the years that follow? The sharp rise in chronic conditions among women in their 40s and 50s demands urgent attention. According to Apollo Health of the Nation data, the incidence of type 2 diabetes among postmenopausal women has soared from 14% to nearly 40%, while obesity now affects up to 86% of women in this demographic. These are not just numbers; they are early warning signs of a health system that has failed to evolve alongside women's physiological realities. Dr. Tripti Dubey, Senior Consultant – Obstetrics, Gynaecology & Robotic Surgery at Apollo Hospitals, Navi Mumbai, shares all you need to know:
The Silent Signals of a Shifting Body
Before menopause sets in, women's bodies undergo subtle, often unspoken transitions. Irregular periods, heavier or lighter bleeding, increased fatigue, mood fluctuations, and unexplained weight gain—these aren't just inconveniences, they are signals. More importantly, they may be early indicators of insulin resistance, polycystic ovarian syndrome (PCOS), thyroid disorders, cardiovascular risks, or even cancer.
In fact, a study published in The Lancet Regional Health – Southeast Asia (2024) found that more than 60% of Indian women with irregular periods in their 30s were later diagnosed with metabolic conditions by their 50s. Yet, the link between menstrual health and chronic disease remains largely unaddressed in public health conversations.
This oversight is not just clinical; it is cultural. Our health infrastructure has been designed around childbearing, not longevity. And while maternal health deserves its due attention, the silence around post-reproductive health care is costing lives.
Rethinking the System: A New Framework for Women's Health
It's time for a radical shift. At Apollo, we've begun piloting midlife metabolic clinics—multidisciplinary hubs that screen for and manage chronic conditions in women aged 40 and above. These clinics don't treat menopause as an isolated event but as part of a broader metabolic journey. They integrate bone density tests, cardiovascular and cancer screenings, mental health counselling, and personalised nutrition plans into routine care.
Moreover, we are advocating for gender-specific medical protocols that recognise the biological and hormonal differences in how diseases present and progress in women. For example, while heart disease is the leading cause of death among Indian women, symptoms often go unrecognised due to their divergence from male-centric diagnostic models.
The Role of Early Intervention
Early menstrual irregularities, changes in mood, skin issues, or unexplained weight shifts are not just cosmetic or transient concerns—they are clinical clues. Educating women to observe these patterns and seek timely intervention could significantly reduce their risk of developing full-blown chronic diseases later in life.
Healthcare providers, too, must recalibrate their approach. A woman in her 30s presenting with period irregularities should not be dismissed with a generic prescription. Instead, her care plan should include screening for insulin resistance, PCOS, thyroid function, and cardiovascular and cancer risk markers.
Beyond the Clinic: Policy and Awareness
A true transformation will require more than clinical change. It demands policy reform. India's public health programmes must expand beyond maternal care to include preventive health checkups for midlife women, public awareness campaigns on perimenopausal changes, and insurance schemes that cover long-term chronic care.
Educational institutions and workplaces must also play their part by creating safe spaces for menstrual and menopausal conversations and by supporting women through these physiological transitions with empathy and resources.
The Path Ahead
If the body whispers before it screams, the menstrual cycle is the first whisper. It tells us when something is off—long before a formal diagnosis appears on a chart. Yet most women, conditioned to normalise pain, irregularity, and discomfort, miss the message. And when the silence stretches too long, the consequences often become irreversible.
The question is not whether we can build a better system for women's health. The question is: Will we listen in time?
Because a missed period isn't always about pregnancy. Sometimes, it's about a much larger, more complex story—one that could change the trajectory of a woman's entire life.
The News18 Lifestyle section brings you the latest on health, fashion, travel, food, and culture — with wellness tips, celebrity style, travel inspiration, and recipes. Also Download the News18 App to stay updated!
First Published:
May 15, 2025, 10:05 IST
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
21 minutes ago
- Time of India
Singapore SCID case: Indian-origin baby beats rare disorder; Stem-cell transplant saves life
Representative photo A 19-month-old Indian-origin boy in Singapore has made a remarkable recovery from a rare and life-threatening genetic disorder, thanks to a timely stem-cell transplant , according to a report by The Straits Times. Mannat Singh was just six days old when doctors diagnosed him with severe combined immunodeficiency (SCID), a condition that left him dangerously vulnerable—even to something as common as the flu. Born in Singapore, Mannat holds the distinction of being the first baby in the country to be diagnosed with SCID at birth. He underwent a successful stem-cell transplant in 2023, a crucial step that came before the onset of symptoms. Today, Mannat is thriving, the newspaper reported. His specific condition, known as Artemis SCID , is an extremely rare and recessive form of radiosensitive SCID. This meant certain treatments like radiation and specific scans were off-limits. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo Without intervention, Mannat would not have survived beyond his first birthday, the report said. His mother, Harminder Kaur, a 39-year-old nurse, spoke about the emotional weight she carried after learning about her son's condition. 'Because I made him this way,' she said, recalling her initial feelings of guilt and fear. His father, Harminder Singh, also 39 and an IT consultant, admitted the prognosis was hard to accept. 'It did not help our state of mind when his odds were stacked against him,' he said. Now, with Mannat healthy and growing, Kaur said, 'I feel now that life has returned to normal and we have put the past behind us.' The diagnosis was made at KK Women's and Children's Hospital (KKH) through the National Expanded Newborn Screening (NENS) programme. Launched in 2006, NENS initially aimed to screen all newborns in Singapore for metabolic and heritable diseases. In 2019, the programme broadened its scope to include five additional treatable childhood-onset conditions , including SCID and cystic fibrosis. Dr Bianca Chan, a consultant in the rheumatology and immunology service at KKH, emphasized the importance of early detection. 'The highest success is when it is performed within the first three to four months of life, before the baby develops significant infections. This makes SCID screening at birth crucial for early diagnosis to actively prevent infection,' Dr Chan said. She added that the only real cure for SCID is a bone marrow transplant from a healthy donor. Stem cells from the donor's bone marrow can develop into the T-cells that SCID babies critically lack, allowing them to build a functioning immune system. (With PTI inputs)
India Today
an hour ago
- India Today
Appendix cancer on the rise among US millennials, new study finds
From breast and colon to stomach and pancreatic cancers, doctors are now seeing more cases in people under the age of 50. A new study adds another surprising cancer to that list: appendix it remains extremely rare, appendix cancer is steadily increasing, especially among younger generations - millennials and Gen Z in the US, according to new research published in the Annals of Internal study, led by researchers at Vanderbilt University Medical Centre, found that the number of people diagnosed with a type of appendix cancer called appendiceal adenocarcinoma (AA) has spiked in recent decades. Using data from the National Cancer Institute's SEER program, a comprehensive US cancer registry, researchers tracked cases between 1975 and analysed trends by birth cohort and discovered a clear pattern: people born after 1945 showed rising rates of appendix cancer, with the sharpest increases among those born in 1980 and 1985. A study found that the number of people diagnosed with a type of appendix cancer has spiked in recent decades. () advertisementIn fact, rates tripled for the 1980 birth cohort and quadrupled for the 1985 group when compared to people born in 1945."This suggests that something has changed in the environment or lifestyle of newer generations that's contributing to this rise,' said lead researcher Dr. Andreana Holowatyji, assistant professor of hematology and oncology at IS THIS HAPPENING?Unlike more common cancers, the causes of appendix cancer remain appendix, a small pouch attached to the large intestine, was long overlooked and often lumped in with colon cancer. But as diagnostic tools and cancer registries improve, it's become easier to track this specific type of the number of appendectomies (surgical removal of the appendix) has stayed the same over the years, the researchers rules out the possibility that more cancers are simply being discovered because more surgeries are being researchers believe that lifestyle and environmental factors may be to blame. Rising rates of obesity and metabolic disorders among younger generations are a known risk factor for several cancers. But Holowatyji says it's probably not just one thing. The appendix, a small pouch attached to the large intestine, was long overlooked and often lumped in with colon cancer. () "It's likely a combination of influences, things like diet, chemicals in the environment, or even changes in the gut microbiome, that could be triggering changes in the body's cells and increasing the risk," she told IT MATTERS FOR INDIA'S YOUNG ADULTSThough the study was based on US data, the findings carry relevance globally, including for Indian millennials and Gen is also seeing an increase in young people diagnosed with cancers traditionally considered diseases of older inactive for long periods, high intake of processed diets, exposure to pollution, and lack of early screening all play a appendix cancer is still so rare, awareness among doctors and the public is low. This means symptoms, like unexplained bloating, changes in bowel habits, or appetite loss, can easily be dismissed as minor digestive authors of the study are calling for more research into the causes of appendix cancer, especially in younger populations, increased awareness not just among medical professionals but also among young adults themselves. advertisement
Hindustan Times
2 hours ago
- Hindustan Times
Chandigarh: Need to draw lessons from Covid-19 to prepare for future pandemics, says Dr VK Paul
While addressing 63 professionals gathered to attend fourth Postgraduate International Vaccinology Course, Dr Vinod Kumar Paul, member of NITI Aayog, focussed on drawing lessons from the Covid-19 pandemic and preparing for future pandemics. The course is being organised by the department of community medicine and school of public health of PGIMER. In the inaugural ceremony, connecting through video call, Dr Paul highlighted the Indian journey of building Covid-19 vaccine and how India navigated through the pandemic in his keynote address. He said, 'During Covid-19, the vaccine was developed in about 9 months globally and we were in step the global time, but next time around it has to be developed within 100 days of the pandemic being declared. For that we have to work hard today. You need to keep your clinical trials ready, study immune response, biology of potential pathogens, keep the labs ready and create capacity within the industry.' He added, 'During Covid-19 pandemic, nobody came to our rescue, there were hardly any vaccines to be offered to India. We survived because we produced our home vaccines, we survived because we had the capabilities.' Dr Paul emphasised on delivering the vaccine within 100 days whenever the pandemic like situation occurs in future. Dr Rajeev Raghuvanshi, drug controller general of India, delivered the address emphasising the importance of innovation, regulation, and India's leadership in vaccine research. The five-day academic event aims to be a transformative learning experience, equipping participants with advanced knowledge and practical insights in the field of vaccinology.
